Related Experiment Video
Updated: Jul 6, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Causal relationship between matrix metalloproteinase and pulmonary embolism: a bidirectional two-sample Mendelian
1Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei Province, China.
Abstract:
This study evaluated the causal relationship between matrix metalloproteinases (MMPs) and pulmonary embolism using data from the genome-wide association study (GWAS) of pulmonary embolism from the UK Biobank and a GWAS dataset of MMPs based on 5,457 Icelanders aged 65 years and older. MR-Egger, MR-PRESSO, Cochran's Q, and leave-one-out were used for sensitivity analysis. The Mendelian randomization (MR) analysis, based on the IVW analysis, indicated an elevated risk for pulmonary embolism in association with MMP19 (OR = 1.0009, 95%CI: 1-1.0017, P = 0.041), consistent with the weighted median method results (P = 0.015). In addition, despite the negative result from the IVW method (P = 0.554), the weighted median analysis suggested a reduced risk for pulmonary embolism related to MMP12 (OR = 0.9992, 95%CI: 0.9984-1, P = 0.038). No causal associations were found for the other MMPs (including MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP13, MMP14, MMP16, MMP17, and MMP20) on pulmonary embolism (all P > 0.05). The reverse MR analysis revealed no causal associations between pulmonary embolism as exposure and MMPs as outcomes. Sensitivity analyses confirmed the robustness of these findings. In conclusion, this MR analysis revealed the potential causal relationship between MMPs and pulmonary embolism, suggesting that measuring MMPs could help identify people at higher risk of pulmonary embolism, but further research is needed.
Insights
This study investigated matrix metalloproteinases (MMPs) and pulmonary embolism risk. Elevated pulmonary embolism risk was linked to MMP19, while MMP12 showed a potential reduced risk, suggesting MMPs may aid in identifying high-risk individuals.
Area of Science:
- Genetics and Bioinformatics
- Cardiovascular Research
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in various physiological and pathological processes.
- Pulmonary embolism (PE) is a significant cause of morbidity and mortality.
- Understanding the genetic links between MMPs and PE is crucial for risk stratification.
Purpose of the Study:
- To evaluate the potential causal relationship between matrix metalloproteinases (MMPs) and pulmonary embolism (PE) using Mendelian randomization.
- To identify specific MMPs that may influence PE risk.
- To explore the potential of MMPs as biomarkers for PE risk assessment.
Main Methods:
- Mendelian randomization (MR) analysis utilizing genome-wide association study (GWAS) data for PE (UK Biobank) and MMPs (Icelandic cohort).
- Employed instrumental variable analysis (IVW) and weighted median methods for primary analysis.
- Conducted sensitivity analyses including MR-Egger, MR-PRESSO, Cochran's Q, and leave-one-out to ensure result robustness.
Main Results:
- Mendelian randomization analysis indicated an elevated risk of pulmonary embolism associated with MMP19 (OR=1.0009, P=0.041).
- Weighted median analysis suggested a reduced risk of pulmonary embolism related to MMP12 (OR=0.9992, P=0.038), despite non-significant IVW results.
- No significant causal associations were found for other tested MMPs (MMP1, MMP2, MMP3, MMP7-10, MMP13, MMP14, MMP16, MMP17, MMP20) with pulmonary embolism.
Conclusions:
- This MR study suggests a potential causal link between specific MMPs and pulmonary embolism.
- MMP19 and MMP12 warrant further investigation for their roles in PE pathogenesis and as potential risk biomarkers.
- Additional research is necessary to confirm these findings and explore therapeutic implications.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction

